Usefulness of increased 18F-FDG uptake for detecting local recurrence in patients with extremity osteosarcoma treated with surgical resection and endoprosthetic replacement

Skeletal Radiology

Volumn 44, Issue 4, 2015, Pages 529-537

  Chang, Kyoung Jin ^a   Kong, Chang Bae ^a   Cho, Wan Hyeong ^a   Jeon, Dae Geun ^a   Lee, Soo Yong ^a   Lim, Ilhan ^a   Lim, Sang Moo ^a  

^a Korea Cancer Center Hospital   (South Korea)

Author keywords

18F FDG; Endoprosthetic replacement; Local recurrence; Osteosarcoma; SUVmax

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENDOPROSTHESIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOSARCOMA; OUTCOME ASSESSMENT; PET-CT SCANNER; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; BONE NEOPLASMS; COMPUTER ASSISTED TOMOGRAPHY; LIMB; MULTIMODAL IMAGING; NEOPLASM RECURRENCE, LOCAL; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; PROSTHESES AND ORTHOSES; PROSTHESIS IMPLANTATION; RADIOGRAPHY; REPRODUCIBILITY; SCINTISCANNING;

ADOLESCENT; BONE NEOPLASMS; EXTREMITIES; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; MALE; MULTIMODAL IMAGING; NEOPLASM RECURRENCE, LOCAL; OSTEOSARCOMA; POSITRON-EMISSION TOMOGRAPHY; PROSTHESES AND IMPLANTS; PROSTHESIS IMPLANTATION; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84925489229     PISSN: 03642348     EISSN: 14322161     Source Type: Journal    
DOI: 10.1007/s00256-014-2063-7     Document Type: Article

References (32)

1. Biermann JS, Adkins DR, Benjamin RS, Brigman B, Chow W, Conrad 3rd EU, et al. Bone cancer. Bone Cancer J Natl Compr Canc Netw. 2010;8(6):688–712.
2. Zeegan EN, Aponte-Tinao LA, Hornicek FJ, Gebhardt MC, Mankin HJ. Survivorship analysis of 141 modular metallic endoprostheses at early followup. Clin Orthop Relat Res. 2004;420:239–50.
3. Tiwari A. Current concepts in surgical treatment of osteosarcoma. J Clin Orthop Trauma. 2012;3:4–9.
4. Yin K, Liao Q, Zhong D, Ding J, Niu B, Long Q, et al. Meta-analysis of limb salvage versus amputation for treating high-grade and localized osteosarcoma in patients with pathological fracture. Exp Ther Med. 2012;4(5):889–94.
5. Weeden S, Grimer RJ, Cannon SR, Taminiau AH, Uscinska BM. European Osteosarcoma Intergroup. The effect of local recurrence on survival in resected osteosarcoma. Eur J Cancer. 2001;37(1):39–46.
6. Takeuchi A, Lewis VO, Satcher RL, Moon BS, Lin PP. What are the factors that affect survival and relapse after local recurrence of osteosarcoma? Clin Orthop Relat Res. 2014;472(10):3188–95.
7. Grimer RJ, Sommerville S, Warnock D, Carter S, Tillman R, Abudu A, et al. Management and outcome after local recurrence of osteosarcoma. Eur J Cancer. 2005;41(4):578–83.
8. Brenner W, Bohuslavizki KH, Eary JF. PET imaging of osteosarcoma. J Nucl Med. 2003;44(6):930–42.
9. Fletcher BD. Imaging pediatric bone sarcomas. Diagnosis and treatment-related issues. Radiol Clin N Am. 1997;35(6):1477–94.
10. Hargreaves BA, Worters PW, Pauly KB, Pauly JM, Koch KM, Gold GE. Meta-induced artifacts in MRI. AJR Am J Roentgenol. 2011;197(3):547–55.
11. Boas FE, Fleischmann D. Evaluation of two iterative techniques for reducing metal artifacts in computed tomography. Radiology. 2011;259(3):894–902.
12. Strobel K, Stumpe KD. PET/CT in musculoskeletal infection. Semin Musculoskelet Radiol. 2007;11(4):353–64.
13. Zhuang H, Chacko TK, Hickeson M, Stevenson K, Feng Q, Ponzo F, et al. Persistent non-specific FDG uptake on PET imaging following hip arthroplasty. Eur J Nucl Med Mol Imaging. 2002;29(10):1328–33.
14. Heiba SI, Luo J, Sadek S, Macalental E, Cacavio A, Rosen G, et al. Attenuation-correction induced artifact in F-18 FDG PET imaging following total knee replacement. Clin Positron Imaging. 2000;3(6):237–9.
15. Song WS, Jeon DG, Kong CB, Cho WH, Koh JS, Lee JA, et al. Tumor volume increase during preoperative chemotherapy as a novel predictor of local recurrence in extremity osteosarcoma. Ann Surg Oncol. 2011;18(6):1710–6.
16. Kim MS, Cho WH, Song WS, Lee SY, Jeon DG. Time dependency of prognostic factors in patients with stage II osteosarcomas. Clin Orthop Relat Res. 2007;463:157–65.
17. Kong CB, Song WS, Cho WH, Oh JM, Jeon DG. Local recurrence has only a small effect on survival in high-risk extremity osteosarcoma. Clin Orthop Relat Res. 2012;470(5):1482–90.
18. Byun GH, Kong CB, Lim I, Kim BI, Choi CW, Song WS, et al. Comparison of (18)F-FDG PET/CT and (99 m)Tc-MDP bone scintigraphy for detection of bone metastasis in osteosarcoma. Skeletal Radiol. 2013;42(12):1673–81.
19. Coffin CM, Lowichik A, Zhou H. Treatment effects in pediatric soft tissue and bone tumors: practical considerations for the pathologist. Am J Clin Pathol. 2005;123:75–90.
20. Heck Jr RK, Peabody TD, Simon MA. Staging of primary malignances of bone. CA Cancer J Clin. 2006;56(6):366–75.
21. Jeon DG, Song WS, Kong CB, Cho WH, Cho SH, Lee JD, et al. Role of surgical margin on local recurrence in high risk extremity osteosarcoma: a case-controlled study. Clin Orthop Surg. 2013;5(3):216–24.
22. Cho A, Hur J, Kang WJ, Cho HJ, Lee JH, Yun M, et al. Usefulness of FDG PET/CT in determining benign from malignant endobronchial obstruction. Eur Radiol. 2011;21(5):1077–87.
23. Kwee TC, Kwee RM, Alavi A. FDG-PET for diagnosing prosthetic joint infection: systematic review and metaanalysis. Eur J Nucl Med Mol Imaging. 2008;35(11):2122–32.
24. Duhaylongsod FG, Lowe VJ, Patz Jr EF, Vaughn AL, Coleman RE, Wolfe WG. Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography. Ann Thorac Surg. 1995;60(5):1348–52.
25. Gaetano B, Stefano F, Mario M, Fanco B, Piero P, Marco M, et al. Predictive factors for local recurrence in Osteosarcoma 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy. Acta Orthop Scand. 1998;69(3):230–6.
26. Picci P, Sangiorgi L, Rougraff BT, Neff JR, Casadei R, Campanacci M. Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma. J Clin Oncol. 1994;12(12):2699–705.
27. Wasselius J, Malmstedt J, Kalin B, Larsson S, Sundin A, Hedin U, et al. High 18F-FDG uptake in synthetic aortic vascular grafts on PET/CT in symptomatic and asymptomatic patients. J Nucl Med. 2008;49(10):1601–5.
28. Hagerty RD, Salzmann DL, Kleinert LB, Williams SK. Cellular proliferation and macrophage populations associated with implanted expanded polytetrafluoroethylene and polyethyleneterephthalate. J Biomed Mater Res. 2000;49(4):489–97.
29. Salzmann DL, Kleinert LB, Berman SS, Williams SK. Inflammation and neovascularization associated with clinically used vascular prosthetic materials. Cardiovasc Pathol. 1999;8(2):63–71.
30. Reuther G, Mutschler W. Detection of local recurrent disease in musculoskeletal tumors: magnetic resonance imaging versus computed tomography. Skeletal Radiol. 1990;19(2):85–90.
31. Cheney M, Giraud C, Goldberg SI, Rosenthal DI, Hornicek FJ, Choy E, et al. MRI surveillance following treatment of extremity soft tissue sarcoma. J Surg Oncol. 2014;109(6):593–6.
32. Zimny M, Siggelkow W, Schroder W, Nowak B, Biemann S, Rath W, et al. 2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer. Gynecol Oncol. 2001;83(2):310–5.